Novavax, Inc. (NASDAQ:NVAX - Get Free Report) has earned an average recommendation of "Hold" from the ten research firms that are currently covering the company, MarketBeat reports. Three research analysts have rated the stock with a sell recommendation, two have given a hold recommendation and five